BioNTech to Report Full Year and Fourth Quarter 2021 Financial Results and Operational Update on March 30, 2022
MAINZ, GERMANY, March 16, 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial...
Month: March 2022
Philips expands its Cybersecurity Services portfolio for healthcare providers
Physician reads radiology images March 16, 2022 Integration of SecureLink critical access management technology with Philips Remote Services framework provides...
Theralogix Launches TheraHemp, the First Enhanced-Absorption CBD Supplement to Achieve Certification by NSF International
TheraHemp successfully completed the rigorous testing and certification process to ensure content accuracy and purity by the public health organization,...
BioSig Technologies, Inc. Appoints John Sieckhaus as Chief Operating Officer
Seasoned electrophysiology commercial leader joins the Company to expand operating capabilitiesWestport, CT, March 16, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies,...
Mountain Valley MD Holdings Appoints Dr. Elizabeth Norton to Advisory Role to Support Key Quicksome™ Vaccine and Cold Chain Projects
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF)...
BioCorRx Announces IRB Approval to Begin Phase I Clinical Trial of BICX104, an Implantable Biodegradable Naltrexone Pellet for the Treatment of Opioid Use Disorder
ANAHEIM, CA, March 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of...
Chiesi USA donates more than $815,000 to local communities and nonprofits in 2021
Chiesi in the Community, Chiesi’s CSR initiative, provides significant contributions to the Triangle community and patient-focused nonprofitsCARY, N.C., March 16,...
Allied Corp Files for Full Psilocybin Patent for Psilonex™ Rx Pharmaceutical
KELOWNA, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
Pure Extracts Exports First Shipment of Cannabis Oil Extracts to German Pharma Company
VANCOUVER, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
Yield10 Bioscience Chief Executive Officer Dr. Oliver Peoples to Present on Development of Camelina Crop for Use in Biofuels at ABLC 2022 Conference
-Establishing the Camelina crop as a replenishable reserve of feedstock oil for biofuels -Winter Camelina could expand acres available for...
Alaunos Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 30, 2022
HOUSTON, March 16, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), today announced that it...
LIXTE Biotechnology Holdings, Inc. to Present at MedInvest Pharmaceutical and Biotechnology Investor Conference
PASADENA, CA, March 16, 2022 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing pharmacologically...
Sana Biotechnology Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates
Plans to present data at multiple scientific conferences in 2022 Expects to file INDs for leading CAR T ex vivo...
Radius Health Announces Leadership Appointments
BOSTON, March 16, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS), today announced appointments to...
Population Health Company AssureCare to Unveil Specialty Pharmacy Solution at HIMSS22
Visit booth #647 at HIMSS22 and see how AssureCare’s Specialty Pharmacy Solution is helping pharmacists deliver quality care and maximize...
RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
Glen Rock, N.J., March 16, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in...
Sight Sciences Announces Appointment of Brenda Becker to Board of Directors
Legislative and health policy expert brings extensive private and public sector experienceMENLO PARK, Calif., March 16, 2022 (GLOBE NEWSWIRE) --...
BetterLife Obtains In Vivo PK Data for BETR-001 Confirming its Bioavailability in Brain
VANCOUVER, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF...
Werewolf Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy of WTX-124 in Delivering IL-2 Selectively to the Tumor Microenvironment
CAMBRIDGE, Mass., March 16, 2022 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical...
Cytovia Therapeutics to Present Preclinical Data for iPSC-derived NK Cells and Flex-NK™ Engager Multispecific Antibodies at 2022 AACR Annual Meeting
AVENTURA, Fla. and NATICK, Mass., March 16, 2022 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK)...
